Economics / Markets

A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.

'Softer Brexit'

Futures markets look unruffled

Need for strong leadership

May’s capacity to deliver Brexit at stake

What goes up beyond expectations …

Despite weak Q1

Corrections a regular feature

'Final blow' to Obama's legacy

Reforms not enough